Skip to content

EY at the 2025 McDermott Forum

Tuesday, January 14, 2025 during Health Care Conference Week in San Francisco

 

Explore health care, life sciences and private equity opportunities and insights across and between industries.

Thank you for joining EY at the McDermott Forum
Tuesday, January 14, 2025
San Francisco

US golden gate bridge skyline

Our latest insights

Firepower report: Life sciences dealmaking trends in 2025

Life sciences dealmaking volume is stable, but value is down – how will smaller, smarter deals help to ensure a more confident future?

January 13, 2025

Health care transformation and growth: 2025 and beyond

Health care leaders need to gear up for growth through investment, divestment and transformation as the sector and market evolve rapidly.

07 Jan 2025 | Kim Dalla Torre & Mike India

2025 private equity trends

Discover six key trends shaping the PE landscape in 2025, from AI and infrastructure to growth strategies and the influence of sovereign wealth funds.

02 Dec 2024 | Timothy Tracy & Ivan Lehon

Download: Post-election health policy outlook (PDF)

The results are in: how Republican control of the White House and Congress could reshape health policy.

30 Nov 2024 | Washington Council Ernst & Young

Recent thought leadership

Optimism for life sciences growth amid policy shifts in 2025

Discover how pharma companies are driving growth in 2025 through tech adoption and strategic deal making.

13 Dec 2024 Arda Ural, PhD

Pulse on MedTech: How the industry is adapting to thrive

Current MedTech industry analysis on dealmaking, financing and commercial strategies, with insights on growth, AI, consumer and future state.

09 Dec 2024 | your local time

How supply chain efficiencies improve patient care

A leading US health system reaches new heights with help from EY US, projecting $80 million in savings. Learn how.

27 Nov 2024 Ryan Siemers

How life sciences CIOs can make the most of GenAI investments

Optimism about GenAI is spreading among CIOs of life sciences organizations, which must focus on key priorities to benefit from the technology. Read more.

11 Nov 2024 Ricardo Vilanova + 4

Private Equity Portco Speed Rounds: Moving at the speed of PE

Join PE professionals for timely discussions on the latest operating and performance issues affecting portfolio companies.

04 Nov 2024

How to create the connected health care system of the future

Learn why enhanced transaction strategy and asset coordination is necessary to build a high-value, high-quality, connected health care system.

09 Oct 2024 Andy Bechtel + 1

How payers can thrive by tackling common transformation challenges

Health care payers are thriving by tackling common operational challenges. Discover how.

09 Oct 2024 Abby Johnson + 3

Value metrics missing from executive compensation and earnings calls

Companies can do a better job of using cash flow and return on capital metrics to create lasting value.

08 Oct 2024 Paul Carbonneau + 3

Pulse of the MedTech Industry report 2024

2024 EY MedTech report on dealmaking, financing, and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.

07 Oct 2024 Jim Welch + 2

How health care executives feel about advances in AI

Together, AI, cloud computing and data lakes can help improve operations across the supply chain, cut costs and strengthen resilience. Learn more.

28 Jun 2024 Arda Ural, PhD + 3

The future of commercial health benefits

Learn about the future of commercial benefits from the 2024 EY-Parthenon Employee Health Benefits Survey.

14 Jun 2024

Key steps for improving biopharma expansion into new markets

As biopharma companies look to new markets for needed growth, leaders need to tailor the expansion approach to the nuances of each market. Learn more.

03 Jun 2024 Ranu Carroll + 1

How value-based care can help boost health system revenue

Risk contracting for value-based care can provide long-term growth for some health care systems. Read the EY-Parthenon analysis.

17 May 2024 Melinda Durr + 3

How the drivers of private equity value creation are changing

Discover the five key drivers in private equity value creation in uncertain markets.

08 May 2024 Bridget Walsh + 3

How to define and execute on a successful retail health business model

The health care industry has seen tremendous investment in retail health but has had mixed results. Read more

15 Feb 2024 Mike India + 2

How pharma can benefit from using GenAI in drug discovery

Using GenAI in drug discovery is a hot topic in the pharmaceutical industry, with speed and cost savings seen as potential benefits. Learn more.

29 Jan 2024 Ranu Carroll + 1

How to leverage generative AI to enhance private equity performance

GenAI strategy execution by PE firms must be informed by a combination of fast and smart moves. Learn more.

07 Nov 2023 Bridget Walsh

5 steps life sciences companies can take now to build resiliency

Life sciences executives focus on cost containment and agility in the face of economic and legislative challenges. Learn more.

07 Aug 2023 Kyle Braden + 2

Why private equity cybersecurity is urgent now

Private equity cybersecurity strategy is critical in investment diligence, deal announcements, value creation and exit. Read more.

30 Mar 2023 John Hauser + 1

    EY Leaders at the McDermott Forum

    Kim Dalla Torre

    EY Global and Americas Health Leader
    Passionate about working smarter for the benefit of patients. Proud resident of Nashville, tennis-loving sailor and mountain climber, mother and wife.
    Nashville, USA

    Arda Ural, PhD

    EY-Parthenon Americas Life Sciences Sector Leader
    Co-author of numerous whitepapers and a frequent speaker about biopharmaceutical strategy at industry conferences. Married father of two.
    New York, USA

    Mike India

    EY-Parthenon Americas Health Sector Leader
    Strategic, pragmatic and detailed advisor interested in solving health care market and operating challenges. Avid Chicago sports fan. Loves pasta. Appreciates any time spent outdoors.
    Chicago, USA

    Ranu Carroll

    EY-Parthenon Americas Life Sciences Sector Leader
    Life sciences sector leader. Strategy and M&A advisor. Avid traveler. Opera enthusiast. Rugby fan. Proud mom of three small humans.
    New York, USA

    Dan Shoenholz

    EY-Parthenon Health Sciences & Wellness Private Equity Leader; EY-Parthenon New York Office Co-Leader
    Strategy leader in health and life sciences sectors. Advisor to corporate and private equity executives. History buff. College basketball fan. Husband and father of two daughters.
    New York, USA

    H. Mallory Caldwell

    EY Americas Strategy and Transactions Corporate & Growth Strategy Leader
    Proven executive and business strategist. Passionate about helping reshape and restructure industry to meet marketplace demands.
    Houston, USA

    John Babitt

    EY Global MedTech Leader
    Experienced life sciences advisor.
    Minneapolis, USA

    Gregory Daco

    EY-Parthenon Chief Economist, Strategy and Transactions, Ernst & Young LLP
    Inclusive leader. Passionate about how economics can help organizations navigate an uncertain world. Husband and dad. Judo black belt, competitive triathlete and avid traveler.
    New York, USA

    Melinda Durr

    EY-Parthenon Principal, Health Sciences and Wellness, Ernst & Young LLP
    Experienced health care strategy consultant. Enjoys exploring her Logan Square neighborhood with her husband. Likes traveling to visit family and friends. Chicago Bulls fan.
    Chicago, USA

    Slava Girzhel

    US Head of Health Care Investment Banking and Senior Managing Director, Ernst & Young Capital Advisors, LLC
    Health care investment banker. M&A and capital markets transactions advisory professional. Strategic advisor. Father. Avid traveler.
    Cleveland, USA

    Anirudh Goel

    Principal, EY-Parthenon, Ernst & Young LLP
    Advisor to corporate and private equity executives. Firm believer in tech’s ability to make a big impact. Deep respect for entrepreneurs.
    New York, USA

    Heather Meade

    Principal, Washington Council, Ernst & Young LLP
    WCEY health care principal, health & tax-exempt policy, former Congressional staffer, recovering ERISA attorney, coalition builder, teacher of civics and math through games. Sideline soccer fan.
    Washington, DC, USA

    Joon-Woo Song

    Partner, Strategy and Execution, EY-Parthenon, Ernst & Young LLP
    15 years with EY-Parthenon: served health payer, provider, health technology companies on strategic and operational matters across their transaction lifecycle. Married father of two boys.
    Chicago, USA

    Julie Lewis Sutherland

    Principal, Health, EY-Parthenon, Ernst & Young LLP
    Focused on driving strategic growth, transformation, and innovative solutions to support health care organizations in achieving sustainable success.
    Seattle, USA

    Where do you find the confidence to face the future of health?

    We know what you have to work with, and what you have to work around: regulations, budget constraints, staffing challenges and legacy systems. With the right pragmatic strategies, with the right collaborators, and with the right technology and talent, you can identify all the points of opportunity.  And deliver it all with a human touch.

    2025 Global economic outlook: steering through conflicting currents

    Join us on January 23 as panelists discuss US exceptionalism, trade and geopolitics, inflation volatility, monetary policy, labor in flux, and fiscal policy.

    Register
    Business people walking in glass lobby with sun reflection

    How EY can help

    •  Health and Wellness Strategy Consulting

      Our Healthcare Strategy Consulting teams help organizations develop digital, transaction and value strategies to build resilience and drive future growth

      Read more

    • Private equity portfolio company value creation services

      Value creation is at the core of every transaction investment thesis. Our team supports private equity firms throughout the investment lifecycle from origination to exit. We bring deep sector, operational and functional experience to identify investment risks and opportunities focused on cash and profit levers to make an investment successful.

      Read more

    • EY Health Technology Services

      Our EY Health Technology Services team embeds digital to position payers and providers for tomorrow. Learn more about our multifaceted offerings. Meta desc

      Read more

    • Private Equity Strategy Consulting

      EY-Parthenon provides Private Equity Strategy Consulting to private equity firms by helping clients maximize value throughout the investment lifecycle.

      Read more

    • Economic Analysis

      Our global economic insights help business leaders monitor risks, integrate them into the business strategy, and act to build resilience.

      Read more

    • Washington Council Ernst & Young

      Washington Council Ernst & Young (WCEY) is a tax, legislative and regulatory group within Ernst & Young LLP that combines the power of a leading professional services organization with the on-the-ground knowledge, personal relationships and attention to detail of a boutique Washington-insider firm.

      Read more
    Contact us
    Find out how EY can support your organization.

    EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.